These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 28554416)

  • 1. Treatment of Older Parkinson's Disease.
    Lenka A; Padmakumar C; Pal PK
    Int Rev Neurobiol; 2017; 132():381-405. PubMed ID: 28554416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonmotor Effects of Conventional and Transdermal Dopaminergic Therapies in Parkinson's Disease.
    Kim R; Jeon B
    Int Rev Neurobiol; 2017; 134():989-1018. PubMed ID: 28805592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence-based initiation of dopaminergic therapy in Parkinson's disease.
    Miyasaki JM
    J Neurol; 2010 Nov; 257(Suppl 2):S309-13. PubMed ID: 21080195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical review of treatment options for select nonmotor symptoms of Parkinson's disease.
    Wood LD; Neumiller JJ; Setter SM; Dobbins EK
    Am J Geriatr Pharmacother; 2010 Aug; 8(4):294-315. PubMed ID: 20869620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteoporosis: A Hidden Nonmotor Face of Parkinson's Disease.
    Metta V; Sanchez TC; Padmakumar C
    Int Rev Neurobiol; 2017; 134():877-890. PubMed ID: 28805587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New treatments for the motor symptoms of Parkinson's disease.
    Vijverman AC; Fox SH
    Expert Rev Clin Pharmacol; 2014 Nov; 7(6):761-77. PubMed ID: 25318835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrajejunal levodopa infusion in Parkinson's disease: a pilot multicenter study of effects on nonmotor symptoms and quality of life.
    Honig H; Antonini A; Martinez-Martin P; Forgacs I; Faye GC; Fox T; Fox K; Mancini F; Canesi M; Odin P; Chaudhuri KR
    Mov Disord; 2009 Jul; 24(10):1468-74. PubMed ID: 19425079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonmotor symptoms in Parkinson's disease: expanding the view of Parkinson's disease beyond a pure motor, pure dopaminergic problem.
    Sung VW; Nicholas AP
    Neurol Clin; 2013 Aug; 31(3 Suppl):S1-16. PubMed ID: 23931951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Neuropsychiatric manifestations in Parkinson's disease].
    Oikonomou E; Paparrigopoulos T
    Psychiatriki; 2015; 26(2):116-30. PubMed ID: 26197101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The hidden sister of motor fluctuations in Parkinson's disease: A review on nonmotor fluctuations.
    Martínez-Fernández R; Schmitt E; Martinez-Martin P; Krack P
    Mov Disord; 2016 Aug; 31(8):1080-94. PubMed ID: 27431515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonmotor predictors for levodopa requirement in de novo patients with Parkinson's disease.
    Erro R; Picillo M; Amboni M; Moccia M; Vitale C; Longo K; Pellecchia MT; Santangelo G; Martinez-Martin P; Chaudhuri KR; Barone P
    Mov Disord; 2015 Mar; 30(3):373-8. PubMed ID: 25648938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Personalized Medicine and Nonmotor Symptoms in Parkinson's Disease.
    Titova N; Chaudhuri KR
    Int Rev Neurobiol; 2017; 134():1257-1281. PubMed ID: 28805572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Speech disorders in Parkinson's disease: pathophysiology, medical management and surgical approaches.
    Dashtipour K; Tafreshi A; Lee J; Crawley B
    Neurodegener Dis Manag; 2018 Oct; 8(5):337-348. PubMed ID: 30223711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parkinson's disease duration determines effect of dopaminergic therapy on ventral striatum function.
    MacDonald AA; Monchi O; Seergobin KN; Ganjavi H; Tamjeedi R; MacDonald PA
    Mov Disord; 2013 Feb; 28(2):153-60. PubMed ID: 23165957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Palliative Care and Nonmotor Symptoms in Parkinson's Disease and Parkinsonism.
    Titova N; Chaudhuri KR
    Int Rev Neurobiol; 2017; 134():1239-1255. PubMed ID: 28805571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact and management of nonmotor symptoms of Parkinson's disease.
    Lyons KE; Pahwa R
    Am J Manag Care; 2011 Oct; 17 Suppl 12():S308-14. PubMed ID: 22087551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management for motor and non-motor complications in late Parkinson's disease.
    Chan DK; Cordato DJ; O'Rourke F
    Geriatrics; 2008 May; 63(5):22-7. PubMed ID: 18447408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-motor extranigral signs and symptoms in Parkinson's disease.
    Wolters ECh
    Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 3():S6-12. PubMed ID: 20083010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonmotor symptoms in nursing home residents with Parkinson's disease: prevalence and effect on quality of life.
    Weerkamp NJ; Tissingh G; Poels PJ; Zuidema SU; Munneke M; Koopmans RT; Bloem BR
    J Am Geriatr Soc; 2013 Oct; 61(10):1714-21. PubMed ID: 24117286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonmotor manifestations of Parkinson's disease.
    Simuni T; Sethi K
    Ann Neurol; 2008 Dec; 64 Suppl 2():S65-80. PubMed ID: 19127582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.